Eight recommendations have been endorsed by emergency medical services clinicians, emergency medicine doctors, surgeons
More drugs with high abuse potential made it through the development process than new drugs with low abuse potential
More than 2-fold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64, ≥65 years
Improvement in mean P/F ratio with no reported toxicity observed among patients hospitalized with COVID-19 and mild-to-moderate ARDS
No reduction in osteoporotic fracture risk seen among women receiving concomitant clodronate and NSAIDs
Extrapolation of the findings from pivotal clinical trials to the approved indication most common for disease severity
Administration of convalescent plasma within 9 days after symptom onset can reduce risk of COVID-19-linked hospitalization
Hospital research publications linked to lower risk-adjusted mortality rates for several conditions and procedures, higher patient satisfaction
Please login or register first to view this content.
